Sudismase (Chiron)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSudismase (Chiron)

Drug Alias NameCG-4505

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionSuperoxide dismutase stimulants

TargetsSuperoxide dismutase

Therapy Area/IndicationsRejection of organ transplantationOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesChiron Spa Cephalon

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesChiron Cephalon

Active IndicationsN/A

Inactive IndicationsRejection of organ transplantationOsteoarthritis

ATC CodeN/A